Mid-life smoking and late-life dementia: The Honolulu-Asia Aging study

Neurobiology of Aging

Volumn 24, Issue 4, 2003, Pages 589-596

  Tyas, Suzanne L ^a   White, Lon R ^b   Petrovitch, Helen ^b   Ross, G Webster ^c   Foley, Daniel J ^d   Heimovitz, Harley K ^e   Launer, Lenore J ^d  

^a UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^b PACIFIC HEALTH RESEARCH INSTITUTE   (United States)

^c DEPARTMENT OF VETERANS AFFAIRS   (United States)

^d NATIONAL INSTITUTE ON AGING   (United States)

^e U S CENSUS BUREAU   (United States)

Author keywords

Alzheimer's disease; Dementia; Elderly; Epidemiology; Longitudinal study; Neuropathology; Risk factors; Smoking; Vascular dementia

Indexed keywords

AGED; AGING; ALZHEIMER DISEASE; ARTICLE; ASIA; AUTOPSY; CEREBROVASCULAR DISEASE; DEMENTIA; EDUCATION; GENOTYPE; HUMAN; MAJOR CLINICAL STUDY; MALE; NEUROPATHOLOGY; PRIORITY JOURNAL; RISK; RISK FACTOR; SMOKING;

AGED; AGING; ANALYSIS OF VARIANCE; CHI-SQUARE DISTRIBUTION; COHORT STUDIES; CONFIDENCE INTERVALS; DEMENTIA; FORECASTING; HAWAII; HUMANS; LOGISTIC MODELS; MALE; MIDDLE AGED; NEOCORTEX; ODDS RATIO; PROSPECTIVE STUDIES; RISK FACTORS; SMOKING;

EID: 0037411518     PISSN: 01974580     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0197-4580(02)00156-2     Document Type: Article

References (32)

1. American Psychiatric Association. Diagnostic and statistical manual of mental disorders, revised (DSM-III-R). 3rd ed. Washington, DC: American Psychiatric Association, 1987.
2. Brayne C., Gill C., Huppert F.A., Barkley C., Gehlhaar E., Girling D.M.et al. Vascular risks and incident dementia: results from a cohort study of the very old. Dement. Geriatr. Cogn. Disord. 9:1998;175-180.
3. Broe G.A., Creasey H., Jorm A.F., Bennett H.P., Casey B., Waite L.M.et al. Health habits and risk of cognitive impairment and dementia in old age: a prospective study on the effects of exercise, smoking and alcohol consumption. Aust. N. Z. J. Public Health. 22:1998;621-623.
4. Chui H.C., Victoroff J.I., Margolin D., Jagust W., Shankle R., Katzman R. Criteria for the diagnosis of ischemic vascular dementia proposed by the State of California Alzheimer's Disease Diagnostic and Treatment Centers. Neurology. 42:1992;473-480.
5. Dallongeville J., Marécaux N., Fruchart J.-C., Amouyel P. Cigarette smoking is associated with unhealthy patterns of nutrient intake: a meta-analysis. J. Nutr. 128:1998;1450-1457.
6. Doll R., Peto R., Boreham J., Sutherland I. Smoking and dementia in male British doctors: prospective study. Br. Med. J. 320:2000;1097-1102.
7. Havlik R.J., Izmirlian G., Petrovitch H., Ross G.W., Masaki K., Curb J.D.et al. APOE-ε4 predicts incident AD in Japanese-American men: the Honolulu-Asia Aging Study. Neurology. 54:2000;1526-1529.
8. Hixson J.E., Vernier D.T. Restriction isotyping of human apolipoprotein E by gene amplification and cleavage with HhaI. J. Lipid Res. 31:1990;545-548.
9. Jorm A.F., Scott R., Cullen J.S., MacKinnon A.J. Performance on the Informant Questionnaire on Cognitive Decline in the Elderly (IQCODE) as a screening test for dementia. Psychol. Med. 21:1991;785-790.
10. Launer LJ, Andersen K, Dewey ME, Letenneur L, Ott A, Amaducci LA, et al., and the EURODEM Incidence Research Group and Work Groups. Rates and risk factors for dementia and Alzheimer's disease: results from EURODEM pooled analyses. Neurology 1999;52:78-84.
11. Launer L.J., Masaki K., Petrovitch H., Foley D., Havlik R.J. The association between midlife blood pressure levels and late-life cognitive function: the Honolulu-Asia Aging Study. JAMA. 274:1995;1846-1851.
12. Markesbery W.R. Oxidative stress hypothesis in Alzheimer's disease. Free Radic. Biol. Med. 23:1997;134-147.
13. McKhann G., Drachman D., Folstein M., Katzman R., Price D., Stadlan E.M. Clinical diagnosis of Alzheimer's disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer's disease. Neurology. 34:1984;939-944.
14. Merchant C., Tang M.-X., Albert S., Manly J., Stern Y., Mayeux R. The influence of smoking on the risk of Alzheimer's disease. Neurology. 52:1999;1408-1412.
15. Mirra SS, Heyman A, McKeel D, Sumi SM, Crain BJ, Brownlee LM, et al., and participating CERAD neuropathologists. The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease. Neurology 1991;41:479-86.
16. Newhouse P.A., Potter A., Kelton M., Corwin J. Nicotinic treatment of Alzheimer's disease. Neurobiol. Aging. 49:2001;268-278.
17. Nordberg A., Hellström-Lindahl E., Lee M., Johnson M., Mousavi M., Hall R.et al. Chronic nicotine treatment reduces β-amyloidosis in the brain of a mouse model of Alzheimer's disease (APPsw). J. Neurochem. 81:2002;655-658.
18. Ott A., Slooter A.J.C., Hofman A., van Harskamp F., Witteman J.C.M., Van Broeckhoven C.et al. Smoking and risk of dementia and Alzheimer's disease in a population-based cohort study: the Rotterdam Study. Lancet. 351:1998;1840-1843.
19. Petrovich H., Nelson J., Snowdon D., Davis D.G., Ross G.W., Li C.Y.et al. Microscope field size and the neuropathologic criteria for Alzheimer's disease. Neurology. 49:1997;1175-1176.
20. Petrovitch H., White L.R., Izmirilian G., Ross G.W., Havlik R.J., Markesbery W.et al. Midlife blood pressure and neuritic plaques, neurofibrillary tangles and brain weight at death: the HAAS. Neurobiol. Aging. 21:2000;57-62.
21. Petrovitch H., White L.R., Ross G.W., Steinhorn S.C., Li C.Y., Masaki K.H.et al. Accuracy of clinical criteria for AD in the Honolulu-Asia Aging Study, a population-based study. Neurology. 57:2001;226-234.
22. SAS Institute Inc. SAS/STAT User's Guide. Release 6.09. Cary NC: SAS Institute Inc.; 1993.
23. Syme S.L., Marmot M.G., Kagan A., Kato H., Rhoads G. Epidemiologic studies of coronary heart disease and stroke in Japanese men living in Japan, Hawaii and California: introduction. Am. J. Epidemiol. 102:1975;477-480.
24. Teng E.L., Hasegawa K., Homma A., Imai Y., Larson E., Graves A.et al. The Cognitive Abilities Screening Instrument (CASI): a practical test for cross-cultural epidemiological studies of dementia. Int. Psychogeriatr. 6:1994;45-58.
25. Traber M.G., van der Vliet A., Reznick A.Z., Cross C.E. Tobacco-related diseases: is there a role for antioxidant micronutrient supplementation? Clin. Chest Med. 21(1):2000;173-187.
26. Tyas S.L. Are tobacco and alcohol use related to Alzheimer's disease? A critical assessment of the evidence and its implications. Addict Biol. 1:1996;237-254.
27. Ulrich J., Johannson-Locher G., Seiler W.O., Stähelin H.B. Does smoking protect from Alzheimer's disease? Alzheimer-type changes in 301 unselected brains from patients with known smoking history. Acta Neuropathol. 94:1997;450-454.
28. US Department of Health and Human Services. Reducing the health consequences of smoking: 25 years of progress. Rockville, MD: U.S. Department of Health and Human Services, Public Health Service, Centers for Disease Control, Center for Chronic Disease Prevention and Heath Promotion, Office on Smoking and Health (DHHS Publication No. [CDC] 89-8411); 1989.
29. Vogt M.T., Wolfson S.K., Kuller L.H. Lower extremity arterial disease and the aging process: a review. J. Clin. Epidemiol. 45:1992;529-542.
30. Wang H.-X., Fratiglioni L., Frisoni G.B., Viitanen M., Winblad B. Smoking and the occurrence of Alzheimer's disease: cross-sectional and longitudinal data in a population-based study. Am. J. Epidemiol. 149:1999;640-644.
31. White L., Petrovitch H., Ross G.W., Masaki K.H., Abbott R.D., Teng E.L.et al. Prevalence of dementia in older Japanese-American men in Hawaii: the Honolulu-Asia Aging Study. JAMA. 276:1996;955-960.
32. Zamani M.R., Allen Y.S. Nicotine and its interaction with β-amyloid protein: a short review. Biol. Psychiatry. 49:2001;221-232.